Evidence map›Paper›PMID 35982938›Full record

ArticleFrontiers in psychiatry2022

Reduced glucocorticoid receptor expression in blood mononuclear cells of patients with borderline personality disorder.

José Manuel López-Villatoro, Karina S MacDowell, Marina Diaz-Marsá, Alejandro De La Torre-Luque, Clara Prittwitz, Alejandra Galvez-Merlin, Juan C Leza, Jose L Carrasco

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

José Manuel López-VillatoroHealth Research Institute, Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Karina S MacDowellDepartment of Pharmacology and Toxicology, Faculty of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain.
Marina Diaz-MarsáBiomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain.
Alejandro De La Torre-LuqueBiomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain.
Clara PrittwitzHealth Research Institute, Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Alejandra Galvez-MerlinFaculty of Psychology, Universidad Complutense de Madrid (UCM), Madrid, Spain.
Juan C LezaDepartment of Pharmacology and Toxicology, Faculty of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain.
Jose L CarrascoBiomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain.
Universidad Complutense de Madrid · ESCentro de Investigación Biomédica en Red de Salud Mental · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESResearch Institute Hospital 12 de Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Abnormal cortisol suppression in borderline personality disorder has been consistently reported in previous studies, suggesting that a hypersensitivity response of the hypothalamic-pituitary-adrenal (HPA) axis might occur in these patients. In this study, the abnormalities of the cortisol response in borderline personality disorder (BPD) are investigated through the cellular expression of the glucocorticoid receptors (GR) in BPD patients and its relationship with traumatic experiences. Methodology: Sixty-nine male and female patients diagnosed with BPD and 62 healthy controls were studied. Peripheral blood mononuclear cells were obtained to investigate the expression of glucocorticoid receptors. Western blot was used to measure protein expression. Statistical correlations of GR expression with BPD clinical features and intensity of previous traumatic events were investigated. Results: A significant decrease in the nuclear expression of glucocorticoid receptors was found in BPD patients compared to healthy controls in a regression analysis controlling for the effect of medication. GR expression decrease correlated significantly with clinical levels of anxiety and depression, but not with previous traumatic experiences in patients. Conclusions: BPD patients had a lower nuclear expression of glucocorticoid receptors than healthy controls, when it was controlled for the effect of medication. The reduced GR expression in BPD patients was not associated with previous traumatic events and might be associated with other aspects of BPD, such as emotional instability; more studies with larger samples of patients are still needed to understand the relevance and the implications of these findings.

Indexed as

borderline personality disordercortisolglucocorticoid receptorstresstrauma

Identifiers

PMID35982938
PMCPMC9379248
OpenAlexW4289518932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.